Cuproptosis Key Gene FDX1 in Alzheimer's Disease
Author Information
Author(s): Chen Guilin, Xi Erwei, Gu Xiaozhen, Wang Huili, Tang Qiqiang
Primary Institution: Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College
Hypothesis
The cuproptosis mechanism may be involved in the pathological process of Alzheimer's disease.
Conclusion
The cuproptosis key gene FDX1 is highly expressed in Alzheimer's disease and may promote cuproptosis in AD neurons.
Supporting Evidence
- FDX1 showed significantly higher expression in AD patients compared to non-AD individuals.
- Knockdown of FDX1 expression improved cell viability and reduced oxidative stress.
- FDX1 expression was higher in patients with the APOE ε4/ε4 genotype.
Takeaway
This study found that a gene called FDX1 is very active in Alzheimer's disease and might help cause problems in the brain. Reducing its activity could help treat the disease.
Methodology
The study used transcriptome analysis, cell experiments, and clinical data collection to investigate FDX1 expression in Alzheimer's disease.
Potential Biases
The study used a public dataset, which may introduce biases due to sample diversity and platform differences.
Limitations
The sample size for clinical validation is relatively small, which may limit the universality and reliability of the research outcomes.
Participant Demographics
30 Alzheimer's patients and 20 healthy controls, with differences in age and gender.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website